참고문헌
- Lemelman MB, Letourneau L, Greeley SAW. Neonatal diabetes mellitus: an update on diagnosis and management. Clin Perinatol 2018;45:41-59. https://doi.org/10.1016/j.clp.2017.10.006
- Sahebi L, Niknafs N, Dalili H, Amini E, Esmaeilnia T, Amoli M, et al. Iranian neonatal diabetes mellitus due to mutation in PDX1 gene: a case report. J Med Case Rep 2019;13:258. https://doi.org/10.1186/s13256-019-2149-x
- Touati A, Errea-Dorronsoro J, Nouri S, Halleb Y, Pereda A, Mahdhaoui N, et al. Transient neonatal diabetes mellitus and hypomethylation at additional imprinted loci: novel ZFP57 mutation and review on the literature. Acta Diabetol 2019;56:301-7. https://doi.org/10.1007/s00592-018-1239-3
- Huang K, Liang L, Fu JF, Dong GP. Permanent neonatal diabetes mellitus in China. BMC Pediatr 2014;14:188. https://doi.org/10.1186/1471-2431-14-188
- im JS, Lim SW, Ahn JH, Song BS, Shim KS, Hwang IT. New Korean reference for birth weight by gestational age and sex: data from the Korean Statistical Information Service (2008-2012). Ann Pediatr Endocrinol Metab 2014;19:146-53. https://doi.org/10.6065/apem.2014.19.3.146
- Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-24. https://doi.org/10.1038/gim.2015.30
- Simsek DG, Ecevit A, Hatipoglu N, Coban A, Arisoy AE, Bas F, et al. Neonatal hyperglycemia, which threshold value, diagnostic approach and treatment?: Turkish Neonatal and Pediatric Endocrinology and Diabetes Societies consensus report. Turk Pediatri Ars 2018;53:S234-8.
- Hay WW Jr, Rozance PJ. Neonatal hyperglycemia-causes, treatments, and cautions. J Pediatr 2018;200:6-8. https://doi.org/10.1016/j.jpeds.2018.04.046
- Suzuki S, Koga M, Niizeki N, Furuya A, Matsuo K, Tanahashi Y, et al. Evaluation of glycated hemoglobin and fetal hemoglobin-adjusted HbA1c measurements in infants. Pediatr Diabetes 2013;14:267-72. https://doi.org/10.1111/pedi.12013
- Kurnaz E, Aycan Z, Yildirim N, Cetinkaya S. Conventional insulin pump therapy in two neonatal diabetes patients harboring the homozygous PTF1A enhancer mutation: need for a novel approach for the management of neonatal diabetes. Turk J Pediatr 2017;59:458-62. https://doi.org/10.24953/turkjped.2017.04.013
- Shah R, McKinlay CJD, Harding JE. Neonatal hypoglycemia: continuous glucose monitoring. Curr Opin Pediatr 2018;30:204-8. https://doi.org/10.1097/MOP.0000000000000592
- Cao B, Gong C, Wu D, Lu C, Liu F, Liu X, et al. Genetic analysis and follow-up of 25 neonatal diabetes mellitus patients in China. J Diabetes Res 2016;2016:6314368.
- Naylor RN, Greeley SA, Bell GI, Philipson LH. Genetics and pathophysiology of neonatal diabetes mellitus. J Diabetes Investig 2011;2:158-69. https://doi.org/10.1111/j.2040-1124.2011.00106.x
- Loomba-Albrecht LA, Glaser NS, Styne DM, Bremer AA. An oral sulfonylurea in the treatment of transient neonatal diabetes mellitus. Clin Ther 2009;31:816-20. https://doi.org/10.1016/j.clinthera.2009.04.003
- Fu JL, Wang T, Xiao XH. Relapsed 6q24-related transient neonatal diabetes mellitus successfully treated with sulfonylurea. Chin Med J (Engl) 2019;132:846-8. https://doi.org/10.1097/cm9.0000000000000147
- Barbetti F, D'Annunzio G. Genetic causes and treatment of neonatal diabetes and early childhood diabetes. Best Pract Res Clin Endocrinol Metab 2018;32:575-91. https://doi.org/10.1016/j.beem.2018.06.008
- Aguilar-Bryan L, Bryan J. Neonatal diabetes mellitus. Endocr Rev 2008;29:265-91. https://doi.org/10.1210/er.2007-0029
- Rubio-Cabezas O, Ellard S. Diabetes mellitus in neonates and infants: genetic heterogeneity, clinical approach to diagnosis, and therapeutic options. Horm Res Paediatr 2013;80:137-46. https://doi.org/10.1159/000354219
- Asl SN, Vakili R, Vakili S, Soheilipour F, Hashemipour M, Ghahramani S, et al. Wolcott-Rallison syndrome in Iran: a common cause of neonatal diabetes. J Pediatr Endocrinol Metab 2019;32:607-13. https://doi.org/10.1515/jpem-2018-0434
- Evliyaoglu O, Ercan O, Ataoglu E, Zubarioglu U, Ozcabi B, Dagdeviren A, et al. Neonatal diabetes: two cases with isolated pancreas agenesis due to homozygous PTF1A enhancer mutations and one with developmental delay, epilepsy, and neonatal diabetes syndrome due to KCNJ11 mutation. J Clin Res Pediatr Endocrinol 2018;10:168-74. https://doi.org/10.4274/jcrpe.5162
- Berg JS. Exploring the importance of case-level clinical information for variant interpretation. Genet Med 2017;19:3-5. https://doi.org/10.1038/gim.2016.106
- Shah RP, Spruyt K, Kragie BC, Greeley SA, Msall ME. Visuomotor performance in KCNJ11-related neonatal diabetes is impaired in children with DEND-associated mutations and may be improved by early treatment with sulfonylureas. Diabetes Care 2012;35:2086-8. https://doi.org/10.2337/dc11-2225
- Svalastoga P, Sulen A, Fehn JR, Aukland SM, Irgens H, Sirnes E, et al. Intellectual disability in KATP channel neonatal diabetes. Diabetes Care 2020;43:526-33. https://doi.org/10.2337/dc19-1013
- Li X, Xu A, Sheng H, Ting TH, Mao X, Huang X, et al. Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: experience from China. Pediatr Diabetes 2018;19:251-8. https://doi.org/10.1111/pedi.12560